Conference abstract · 7 Dec 2015
Conference abstractPublished 7 Dec 2015
Hepatitis C-A readily curable disease
Sargodha Medical College, Pakistan
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Hepatitis C, a chronic, lifelong and life-threatening incurable disease has finally been transformed into a readily curable one. The treatment of hepatitis C has evolved over the years. Initially used IFN monotherapy. Subsequently, combination of ribavirin and IFN or PEG-IFN were used. For the first time, since its discovery in 1989, hepatitis C can be cured without ribavirin and pegylated interferon. PegIFN-based treatment regimens have well-documented adverse event (AE) profiles including influenza-like symptoms and depression, which have led to unfavorable discontinuation rates in clinical trials and RBV also has associated side effects including teratogenicity, hemolytic anemia and rash. PegIFN used to be too toxic for some patients to complete their treatment, had variable and low overall success rate and above all, it was associated with a significant relapse rate. During the past 2 years, treatment regimens with new antiviral drugs have achieved sustained virologic response (SVR) rates of up to 90%-100%. These drugs will also benefit patients with severe fibrosis or cirrhosis by reducing disease progression, hepatic decompensation and hepatocellular carcinoma. HCV NS5B polymerase inhibitor sofosbuvir has emerged as an important component of currently recommended regimens. Antiviral agents with different mechanisms of action are combined in order to increase efficacy and prevent resistance but for a more finite duration. We currently expect an overall low long-term relapse rate.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Commentary · 28 Mar 2022
Curable disease and a common anemia deficiency.
Commentary · 31 Aug 2020
Iron Deficiency Anemia: Curable Disease
Conference abstract · 21 Oct 2019
Malaria is a preventive and curable diseases in Africa
Conference abstract · 26 Nov 2018
The importance of defining hanseniasis according its pathophysiological nature as a non-curable chronic autoimmune and autoinflammatory disease. Bridging the gap between individual and collective medicines based on the p
More from this journal
The newest in Journal of Antivirals & Antiretrovirals.
Conference abstract · 23 Jun 2025
How is really working adaptive immune system in mammals? A novel conception and reverse pathway theory, which will bring novel multibillion super-antibody (sab) technology for curing of all of infectious diseases and cancer!
Conference abstract · 23 Jun 2025
Exploring signature proteins to design a novel multi-epitope vaccine candidate against Mycobacterium tuberculosis: An in-silico approach
Conference abstract · 23 Jun 2025
Correlation Between the Rh/ABO system and infection due to sars cov2 in morocco
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Antivirals & Antiretrovirals
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Syed Amir Abbas Naqvi”

